Pharmablock Sciences to redeem convertible bonds early

Nanjing Pharmablock Sciences Co., Ltd. will initiate the early redemption of its "Yaoshi Convertible Bonds" at a price of yuan 100.62 per bond, which includes the face value and accrued interest. This decision follows the company's stock trading at or above 130% of the current conversion price (yuan 43.69/share) for at least 15 trading days within a 30-day period between July 25, 2025, and August 14, 2025, triggering the conditional redemption clause. The last trading day for the convertible bonds will be September 15, 2025, with the redemption date set for September 18, 2025.

Holders of "Yaoshi Convertible Bonds" who do not convert their bonds into shares by the redemption registration date of September 17, 2025, will have their bonds compulsorily redeemed. The company advises bondholders to consider converting to avoid potential losses, as the current secondary market price of "Yaoshi Convertible Bonds" significantly differs from the redemption price. The bonds will be delisted from the Shenzhen Stock Exchange upon completion of the redemption.

The current conversion price for "Yaoshi Convertible Bonds" is yuan 33.61 per share, adjusted from an initial price of yuan 92.98 per share due to various dividend distributions and downward revisions since issuance. Funds for the redemption are expected to reach the China Securities Depository and Clearing Corporation account by September 23, 2025, with bondholders receiving their redemption payments by September 25, 2025.